| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1074-7613(01)00222-9 |
| P698 | PubMed publication ID | 11672543 |
| P50 | author | Ana Angulo | Q42779933 |
| Peter Ghazal | Q55473304 | ||
| P2093 | author name string | C A Benedict | |
| C F Ware | |||
| W J Britt | |||
| M Ko | |||
| T A Banks | |||
| L Senderowicz | |||
| P2860 | cites work | Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus | Q37385429 |
| Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex | Q39575110 | ||
| Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts | Q39579432 | ||
| Expression of lymphotoxins and their receptor-Fc fusion proteins by baculovirus | Q40865797 | ||
| Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway | Q40896166 | ||
| A serologic survey for viruses and Mycoplasma pulmonis among wild house mice (Mus domesticus) in southeastern Australia | Q41503474 | ||
| Lymphotoxin-beta-deficient mice show defective antiviral immunity. | Q41679119 | ||
| Discrete signaling regions in the lymphotoxin-beta receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-kappaB pathways | Q41728935 | ||
| BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. | Q41740089 | ||
| Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta. | Q42064466 | ||
| Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors | Q43769307 | ||
| Lymphotoxin alpha-/- mice develop functionally impaired CD8+ T cell responses and fail to contain virus infection of the central nervous system | Q45739093 | ||
| Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons | Q45848193 | ||
| Membrane lymphotoxin is required for the development of different subpopulations of NK T cells. | Q52167165 | ||
| Inhibition of fas death signals by FLIPs | Q77485563 | ||
| The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells | Q22254033 | ||
| LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator | Q24308657 | ||
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB | Q24564927 | ||
| TRAIL receptor-2 signals apoptosis through FADD and caspase-8 | Q28142998 | ||
| The lymphotoxin-alpha (LTalpha) subunit is essential for the assembly, but not for the receptor specificity, of the membrane-anchored LTalpha1beta2 heterotrimeric ligand | Q28244596 | ||
| Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-beta receptor | Q28255713 | ||
| TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB | Q28259095 | ||
| Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
| Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction | Q29620054 | ||
| Natural killer cells in antiviral defense: function and regulation by innate cytokines | Q33652468 | ||
| Tumor necrosis factor receptor and Fas signaling mechanisms. | Q33652491 | ||
| Development and maturation of secondary lymphoid tissues. | Q33652498 | ||
| Structure and function of the interferon-beta enhanceosome | Q33671579 | ||
| The pathogenicity of cytomegalovirus | Q33697113 | ||
| Lymphotoxin-alpha-deficient mice can clear a productive infection with murine gammaherpesvirus 68 but fail to develop splenomegaly or lymphocytosis | Q33800151 | ||
| Viral subversion of the immune system | Q33932763 | ||
| The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection | Q35887796 | ||
| Human cytomegalovirus latent infection of granulocyte-macrophage progenitors | Q35945151 | ||
| Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration | Q36365733 | ||
| Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways | Q36381040 | ||
| Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. | Q36688075 | ||
| Requirement for membrane lymphotoxin in natural killer cell development. | Q37206961 | ||
| Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines | Q37376709 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P304 | page(s) | 617-626 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente | |
| P478 | volume | 15 |
| Q53295110 | A Role for Lymphotoxin in Primary Sjögren’s Disease |
| Q59356620 | A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling |
| Q36978605 | A chemokine-like viral protein enhances alpha interferon production by plasmacytoid dendritic cells but delays CD8+ T cell activation and impairs viral clearance. |
| Q35679191 | A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. |
| Q34404551 | Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection |
| Q35984119 | B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunity |
| Q41830269 | B cells, not just for antibody anymore |
| Q40441600 | Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic Cells. |
| Q35790758 | CMV infection attenuates the disease course in a murine model of multiple sclerosis |
| Q33718610 | Constructing non-stationary Dynamic Bayesian Networks with a flexible lag choosing mechanism |
| Q37307520 | Cross-regulation between herpesviruses and the TNF superfamily members |
| Q36229323 | Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands |
| Q38379995 | Cytomegalovirus immune evasion of myeloid lineage cells |
| Q59359836 | Cytomegalovirus: Shape-Shifting the Immune System |
| Q35031970 | Death and survival: viral regulation of TNF signaling pathways |
| Q35489105 | Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection |
| Q24532119 | Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway |
| Q38001203 | Fine-tuning of dendritic cell biology by the TNF superfamily |
| Q28302668 | Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model |
| Q33381845 | Genomic organization and phylogenetic utility of deer mouse (Peromyscus maniculatus) lymphotoxin-alpha and lymphotoxin-beta |
| Q57486496 | HCMV-Encoded NK Modulators: Lessons From and Genetic Variation |
| Q35922058 | Herpes virus entry mediator licenses Listeria infection induced immunopathology through control of type I interferon |
| Q39913109 | Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity |
| Q37948123 | LTβR and CD40: working together in dendritic cells to optimize immune responses. |
| Q36827145 | Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus |
| Q38953303 | Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense |
| Q37243919 | Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus |
| Q35219029 | Lymphotoxin/light, lymphoid microenvironments and autoimmune disease |
| Q89597523 | Map3k14 as a Regulator of Innate and Adaptive Immune Response during Acute Viral Infection |
| Q28221282 | Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control |
| Q57084109 | Modelling non-stationary gene regulatory processes with a non-homogeneous Bayesian network and the allocation sampler |
| Q34022257 | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything |
| Q57009346 | Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus |
| Q37346283 | Multifaceted evasion of the interferon response by cytomegalovirus |
| Q84514962 | NK cells protect secondary lymphoid tissue from cytomegalovirus via a CD30-dependent mechanism |
| Q41581885 | Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses |
| Q36944091 | Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro |
| Q35671858 | Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression |
| Q48546956 | Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients |
| Q34436727 | Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell lines |
| Q40608281 | RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response. |
| Q30845041 | RIG-I mediates the co-induction of tumor necrosis factor and type I interferon elicited by myxoma virus in primary human macrophages |
| Q38760564 | Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer |
| Q36557767 | Restoring immune defenses via lymphotoxin signaling: lessons from cytomegalovirus |
| Q35105651 | Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency. |
| Q41885111 | Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. |
| Q35031966 | Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity. |
| Q34111943 | Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway |
| Q37827868 | Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus |
| Q25257147 | Specific remodeling of splenic architecture by cytomegalovirus. |
| Q40303024 | Stimulation of interferon-beta gene expression by human cytomegalovirus via nuclear factor kappa B and phosphatidylinositol 3-kinase pathway |
| Q27642244 | Structurally Distinct Recognition Motifs in Lymphotoxin-β Receptor and CD40 for Tumor Necrosis Factor Receptor-associated Factor (TRAF)-mediated Signaling |
| Q37036159 | Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways |
| Q27025082 | The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity |
| Q34983824 | To kill or be killed: viral evasion of apoptosis |
| Q46646887 | Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction |
| Q37696074 | Type I interferon: a new player in TNF signaling |
| Q35145651 | Viruses and the TNF-related cytokines, an evolving battle |
| Q36369934 | Whence interferon? Variety in the production of interferon in response to viral infection. |
| Q37182691 | cGAS-STING Signaling Regulates Initial Innate Control of Cytomegalovirus Infection |
Search more.